French Public Health Code
In forceEach public or private healthcare establishment is required to collect and keep the following information for each unit of labile blood product distributed or issued to it for a hospitalised patient:
1° The identification number of the unit prepared in accordance with the national coding system approved by the Agence nationale de sécurité du médicament et des produits de santé ;
2° Identification of the product code in accordance with the national coding system approved by this agency;
3° The circumstances of transport and storage of the unit;
4° Identification of the prescriber and the person responsible for administering the labile blood product;
5° Identification of the patient to whom the unit was administered and the circumstances of this administration, or, where applicable, the date on which the unit was destroyed or returned to the referring blood establishment;
6° When an establishment mentioned in the first paragraph delivers a labile blood product to a patient hospitalised in another of these establishments, the identification of this establishment and the date and circumstances of this delivery;
7° Any adverse reaction occurring in a recipient of labile blood products, any serious incident and any post-donation information concerning labile blood products transfused in this establishment.
